Nu Skin Enterprises, Inc. (NYSE:NUS) Director Sells $13,086.89 in Stock

Nu Skin Enterprises, Inc. (NYSE:NUS) Director Emma S. Battle sold 1,693 shares of the company’s stock in a transaction that occurred on Friday, February 21st. The shares were sold at an average price of $7.73, for a total value of $13,086.89. Following the completion of the sale, the director now owns 17,530 shares in the company, valued at $135,506.90. This represents a 8.81 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

Nu Skin Enterprises Trading Down 2.6 %

Shares of NYSE:NUS opened at $7.87 on Thursday. Nu Skin Enterprises, Inc. has a 12-month low of $5.95 and a 12-month high of $14.04. The business has a 50 day moving average of $6.91 and a 200-day moving average of $7.28. The company has a quick ratio of 1.17, a current ratio of 1.82 and a debt-to-equity ratio of 0.56. The stock has a market cap of $391.32 million, a PE ratio of -2.67 and a beta of 1.17.

Nu Skin Enterprises (NYSE:NUS) last released its quarterly earnings results on Thursday, February 13th. The company reported $0.38 earnings per share for the quarter, topping the consensus estimate of $0.24 by $0.14. Nu Skin Enterprises had a positive return on equity of 5.86% and a negative net margin of 8.46%. The business had revenue of $445.55 million during the quarter, compared to analysts’ expectations of $441.10 million. As a group, equities research analysts forecast that Nu Skin Enterprises, Inc. will post 1.05 earnings per share for the current year.

Nu Skin Enterprises Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, March 5th. Shareholders of record on Monday, February 24th will be given a dividend of $0.06 per share. The ex-dividend date is Monday, February 24th. This represents a $0.24 dividend on an annualized basis and a dividend yield of 3.05%. Nu Skin Enterprises’s payout ratio is presently -8.14%.

Analyst Upgrades and Downgrades

A number of research firms recently weighed in on NUS. StockNews.com raised Nu Skin Enterprises from a “hold” rating to a “buy” rating in a report on Tuesday. DA Davidson decreased their price objective on shares of Nu Skin Enterprises from $11.00 to $7.00 and set a “neutral” rating on the stock in a report on Friday, December 20th.

Institutional Investors Weigh In On Nu Skin Enterprises

Institutional investors have recently made changes to their positions in the stock. Creative Planning lifted its position in shares of Nu Skin Enterprises by 43.0% during the 3rd quarter. Creative Planning now owns 41,226 shares of the company’s stock valued at $304,000 after acquiring an additional 12,398 shares during the period. Ballentine Partners LLC acquired a new position in shares of Nu Skin Enterprises during the 3rd quarter worth $133,000. Covestor Ltd lifted its position in shares of Nu Skin Enterprises by 110.9% during the 3rd quarter. Covestor Ltd now owns 10,140 shares of the company’s stock worth $75,000 after buying an additional 5,333 shares during the last quarter. Versor Investments LP acquired a new stake in Nu Skin Enterprises in the third quarter valued at about $86,000. Finally, Aigen Investment Management LP bought a new position in shares of Nu Skin Enterprises in the third quarter worth about $111,000. 82.84% of the stock is currently owned by institutional investors.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.